Author name: Swaraj Paul Barooah

.

Guest Post: The Expanding Scope of Performers’ Rights

/ By / Copyright

Shashank Mangal brings us his 2nd post in our fellowship series. This post questions the scope of performers’ rights and raises some interesting questions regarding the same. This is Shashank’s 2nd post in our fellowship series. You can view his first post here. The Expanding Scope of Performers’ Rights The Copyright Act provides for an inclusive or illustrative definition of “performer” as it says that – “performer” includes an actor, singer, musician, dancer, acrobat, juggler, conjurer, snake charmer, a person […]

Guest Post: The Expanding Scope of Performers’ Rights Read More »

Guest Post: Don’t Copy My Architecture

/ By / Copyright

Shashank Mangal, a 4th year student from ILS law college, Pune brings us a point by point discussion of copyright in architecture under the Copyright Act. This is Shashank’s first submission to the 2nd Annual SpicyIP Fellowship applicant series. If I’m not mistaken, this is the first time the blog has looked into this aspect of copyright law in any detail. Don’t copy my architecture The scope of this post is confined to copyright in architecture. As per Section 13

Guest Post: Don’t Copy My Architecture Read More »

Guest Post: Property Rights in the Virtual World

/ By / Copyright, Trademark

After a brief hiatus, we come back to our 2nd Annual SpicyIP Fellowship applicant series. In this post, Deepshikha Malhotra brings us an interesting post on property rights the virtual world! This is Deepshikha’s 2nd entry to our fellowship applicant series. Her first post is available here. Property Rights in the Virtual World If being materialistic in real life isn’t enough, we have plenty of opportunities to be so in the virtual world as well. From something as simplistic as

Guest Post: Property Rights in the Virtual World Read More »

Herceptin’s biosimilar: off patent and still expensive. What now?

/ By / Patent

The access-to-medicines folks as well as Big Pharma backers will want to take note of the latest ‘issue’ arising in the pharmaeutical pricing arena. As we had reported earlier last year, Roche had decided to drop its pursuance of patents over breast cancer biologics drug Herceptin (Trastuzumab). However, if anyone thought this meant a cheaply available generic would soon be available, it turns out that they’d be mistaken. US-based Mylan along with partner Bangalore-based Biocon received regulatory approval a few

Herceptin’s biosimilar: off patent and still expensive. What now? Read More »

Guest Post: International Patent Filing Strategy Survey for Patent Attorneys in the Biotechnology and Pharmaceutical industries

/ By / Patent

One of our regular readers, a patent agent and law student from US has sent in a request for our patent attorney readers. Please see as below: Dear SpicyIP readers: A team of law students, who are members of the Intellectual Property law Fellowship at the Thomas Jefferson School of Law in San Diego, California, are working on a Research Project directed toward aiding patent attorneys in developing international patent filing strategies for biotechnology and pharmaceutical companies. With the help

Guest Post: International Patent Filing Strategy Survey for Patent Attorneys in the Biotechnology and Pharmaceutical industries Read More »

Update: Nexavar only for western patients

/ By / Patent

On January 21st, 2014 reporter Ketaki Gokhale of Bloomberg BusinessWeek published a shocking statement by Bayer Chief Executive Officer Marijn Dekkers as part of their story on drug patents and prices. With respect to the Nexavar drug which we’ve covered extensively on this blog, he was quoted as saying: “We did not develop this medicine for Indians,” “We developed it for western patients who can afford it.” Nexavar of course was the kidney cancer drug for which the IPAB upheld India’s

Update: Nexavar only for western patients Read More »

Patent analytics apps and an infographic of the Indian Patent System

/ By / Patent

Rubal Walia from Relecura sends us the infographic pictured below, on the state of Indian Patents by looking over data (sources mentioned in the note at the bottom) from the last few years. Their numbers indicate that while the number of patent applications has slowly been rising, the number of patents granted annually has decreased substantially. Those interested in patent analytics may also want to check out Bangalore/SF based Relecura’s mobile app which, to my knowledge, is one of only

Patent analytics apps and an infographic of the Indian Patent System Read More »

INTA’s 136th Annual Meeting

/ By / Event, Sponsored

The International Trademark Association’s (INTA) 136th Annual Meeting will be held in Asia for the first time – in Hong Kong SAR, China on May 10-14, 2014. The Annual Meeting has made its mark as the largest and most dynamic IP and trademark event in the world. More than 8,500 professionals from over 140 countries are expected to attend. Five days of international trademark and intellectual property education sessions led by the most acclaimed IP professional in the world will

INTA’s 136th Annual Meeting Read More »

Guest Post: Delhi HC simplifies a complex Asana

/ By / Copyright, Trademark

Sadhvi Sood brings us her third post in our 2nd Annual SpicyIP Fellowship applicant series. This post examines a recent Delhi High Court case wherein ‘pranic healing’, the phrase as well as techniques were claimed to be protected by trademark and copyright law respectively. You can view Sadhvi’s previous posts here. As a note for our readers, our application window for our Fellowship has now closed. We should hopefully be able to go through all the submitted applications and announce

Guest Post: Delhi HC simplifies a complex Asana Read More »

Guest Post: Is Nestlé Seeking a Patent over an Indian Home Remedy?

/ By / Traditional Knowledge

In this guest post, Sadhvi Sood discusses reports of Nestle’s patent application for Fennel Flower (Kala Jeera) vis-a-vis the concept of traditional knowledge. This is Sadhvi’s second submission to our SpicyIP Fellowship series. You can view her first submission here. Is Nestlé Seeking a Patent over an Indian Home Remedy? Since time immemorial, home remedies have been used in India to effectively treat both quotidian health problems like the common flu and chronic diseases like sinusitis etc. When it was reported

Guest Post: Is Nestlé Seeking a Patent over an Indian Home Remedy? Read More »

Scroll to Top